Press Releases

DÜSSELDORF, Germany, Nov. 18, 2019 /PRNewswire/ -- Nisonic AS, a startup co-founded by SINTEF and Cofounder in Norway, aims to make intracranial pressure (ICP) assessment as simple and easy as measuring body temperature. Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP. Th

KING OF PRUSSIA, Pa., Nov. 18, 2019 /PRNewswire/ -- Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will pr

GERMANTOWN, Md., Nov. 18, 2019 /PRNewswire/ -- Triple-Gene LLC, a clinical stage cardiovascular gene therapy company and majority owned subsidiary of Intrexon Corporation (NASDAQ: XON), yesterday

DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX® Cosmetic, has announced the first-ever National BOTOX® Cosmetic Day kicking off on November 20. The celebration recognizes the impact this iconic aesthetic brand, which is the #1 selling treatment of its kind1,&nb

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in patients with

NASHVILLE, Tenn., Nov. 18, 2019 /PRNewswire/ -- SaVida Health, a leader in medication-assisted treatment for opioid and alcohol addiction, is opening a new outpatient treatment center in Abingdon, Virginia on November 18. SaVida is expanding its network of comprehensive, patient-centered addiction treatm

JERUSALEM, Nov. 18, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) announced today that enrollment and randomization of 12,463 participants in the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal influenza vaccine candidate is complete.

LOS ANGELES, Nov. 18, 2019 /PRNewswire/ -- Los Angeles advertising agency, Kastner North America, widely known in the industry for its inn

Event to feature renowned leaders in the field of immunotherapy and neuro-oncology TORONTO and HOUSTON, Nov. 18, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will host a lunch

PRINCETON, N.J., Nov. 18, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will be presenting at the PCG Spotlight Series Conference taking place on